Early Kidney Damage Markers after Deferasirox Treatment in Patients with Thalassemia Major: A Case-Control Study

Table 3

Comparison of abnormal U. Alb/CREA (greater than 30) in case and control groups.

			U. Alb/CREA		Total	value
			Less than 30	30 to 300
Studied groups	Deferoxamine	Count	16	3	19	0.64
		Within studied group	84.2%	15.8%	100%
	Deferasirox	Count	16	5	21
		Within studied group	76.2%	23.8%	100%
	Control	Count	5	0	5
		Within studied group	100	0	100
Total		Count	37	8	45
		Within studied group	82.2	17.8	100

Alb: albumin; CREA: creatinine; U: urinary.